Mehta Vishal M, Mandala Cassie, Foster Danielle, Petsche Timothy S
Fox Valley Orthopaedic Institute, Geneva, Illinois, USA.
Orthopedics. 2010 Jan;33(1):12. doi: 10.3928/01477447-20091124-15.
This study compared the revision rates after autograft and allograft bone-patella tendon-bone anterior cruciate ligament (ACL) reconstruction. All bone-patella tendon-bone ACL reconstructions performed by a single surgeon between January 2000 and December 2006 were identified by retrospective chart review. Two hundred twenty-three patients met the inclusion criteria and 173 patients were available for follow-up. One hundred forty-two patients underwent bone-patella tendon-bone autograft reconstruction, and 31 patients underwent bone-patella tendon-bone allograft reconstruction. At a mean follow-up of 49 months (range, 11-91 months), revision rates were 0.7% (1/142) in the bone-patella tendon-bone autograft group versus 9.7% (3/31) in the bone-patella tendon-bone allograft group (P=.02). Subjective International Knee Documentation Committee (IKDC) scores of nonrevised (surviving) grafts in the bone-patella tendon-bone autograft group were 98.3 versus 95.2 in the bone-patella tendon-bone-allograft group (P=.0006). Tegner scores of nonrevised grafts in the bone-patella tendon-bone-autograft group were 6.2 vs 6.5 in the bone-patella tendon-bone-allograft group (P=.03). Fourteen of the 31 (45%) allografts were irradiated and all failures occurred in irradiated grafts. When irradiated grafts were excluded, no difference in revision rates was found. Anterior cruciate ligament reconstruction with the use of bone-patella tendon-bone allografts is associated with a higher revision rate when compared to bone-patella tendon autograft reconstruction. In addition, when comparing surviving grafts, the subjective IKDC scores are higher in the autograft group. When irradiated grafts are excluded, no difference in revision rates was found. Surgeons should be aware of the higher revision rate associated with allograft ACL reconstruction when counseling patients on graft options.
本研究比较了自体骨-髌腱-骨与同种异体骨-髌腱-骨重建前交叉韧带(ACL)后的翻修率。通过回顾性病历审查,确定了2000年1月至2006年12月间由同一位外科医生进行的所有骨-髌腱-骨ACL重建手术。223例患者符合纳入标准,173例患者可供随访。142例患者接受了骨-髌腱-骨自体移植重建,31例患者接受了骨-髌腱-骨同种异体移植重建。平均随访49个月(范围11 - 91个月),骨-髌腱-骨自体移植组的翻修率为0.7%(1/142),而骨-髌腱-骨同种异体移植组为9.7%(3/31)(P = 0.02)。骨-髌腱-骨自体移植组未翻修(存活)移植物的主观国际膝关节文献委员会(IKDC)评分为98.3,而骨-髌腱-骨同种异体移植组为95.2(P = 0.0006)。骨-髌腱-骨自体移植组未翻修移植物的Tegner评分为6.2,骨-髌腱-骨同种异体移植组为6.5(P = 0.03)。31例同种异体移植物中有14例(45%)接受了辐照,所有失败均发生在辐照移植物中。排除辐照移植物后,未发现翻修率有差异。与骨-髌腱-骨自体移植重建相比,使用骨-髌腱-骨同种异体移植物进行前交叉韧带重建的翻修率更高。此外,比较存活移植物时,自体移植组的主观IKDC评分更高。排除辐照移植物后,未发现翻修率有差异。在就移植物选择向患者提供咨询时,外科医生应意识到同种异体ACL重建相关的较高翻修率。